Member Info for Supermobileman

Straight in with his usual personal insults from motormouth OTM.

Post reported.

Avion can't refuse to do Phase 3. There are normally timescales which to conduct it. If it was the case Avion refused for no reasons, they would have had their license revoked by Immupharma by now for breach of contract. This clause is normal in the pharmaceutical licensing agreements.

So why hasn't Avion started Phase 3? and why hasn't Immupharma revoked/terminated Avion's license?

I'll let you work that one out yourself.

Nolupus,

Some years back, you admitted yourself and said you met and spoken to Sylviane Muller.

Do you deny that?

Nolupus the question is simple, did you not repeatedly failed attempts to secure an R&D role with Immupharma and several other companies?

Yes or No?

You're so sure of yourself a fundraise was coming, you went and topped up to 3 million shares. You must be hurting. What an idiot.

Kapiglucagon internal sales forecast is $3 Billion PER YEAR over ten years.

A ten-year sales forecast is almost always presented per year rather than as a single ten-year aggregate.

In the video, Tim Franklin's slide forecast in my opinion is vague and 'incorrectly' written.

$3 Billion in total over ten years would equate to only $300m per year which is far too low and far too conservative. Immupharma said Kapiglucagon if approved, would dominate the markets. The world markets is huge. Based on Immupharma market share forecast in the video, $300m per year or $3Billion over ten years does not add up but $3 Billion per year would be about correct.

Tim McCarthy said "$3 Billion per year" in the video.

Nolupus,

Could you tell us how long Immpharma last Phase 3 trial went on for from 1st dose to results? Was it three years? You certainly have short memories.

It all depends on the number of pateints required by the FDA and the budget of the partner willing to spend. A big pharma with deep pockets can recruit patients a lot quicker by hiring more staff involved in the recruitment process. Immpharma done theirs on a low budget.

Last word should be "yourself" and not "you".

Lordlooneyofwally is a contrarian ingrate person.

Lord posts nothing informative or constructive because lord's too coward to do so. All lord's posts are sarcastic and nothing but lambast, berate, criticize, etc, of others because that's an easy job to do.

Lord talk the talk. Why don't he put his money where his mouth is and sell his shares and get the hell out and be at peace with you

Juxtaposition, why are you so fixated on Sinitta's "only two weeks to go" statement?

If she did posted the reason why, there is someone on this board will report it as inside information.

All those who contacted Lisa or anyone in Immupharma should keep it to themselves, whether the news is good or bad.

Juxtaposition, you are abusing and attacking OSD. This is unacceptable.

One....many, are you accepting Juxtaposition's behaviour is allowed. Are you going to report it LSE?

Rain chucking it down here non stop for hours. Remind me of Noah's flood. As OSD said, biblical proportion.

Yep, I'm sure after Keta's M&A, being a City guy, he will next go for the job as the Prime Minister of UK.

Non-Executive Directors are not proper employees of Immupharma. Some stupid idiots thinks they are full time employees and get involved in everyday operations.

My take is Ketan only been recently hired to meet ghe requirement in Governance Code so in preparation for possible significant income Immupharma will receive. One of the roles of an independent Non-Executive Director is they are there to ensure accountability.

Incorrect J.kemp, Lisa is not an independent Non-Executive Director.

She is an Non-Executive Director and fully employed by Immupharma. She is not an independent.

Immupharma need the requirement of at least two INDEPENDENT Non-Executive Directors.

J.kemp,

Can you tell me the other two non-executives apart from Ketan.

Correction.

Executive and not Exexcutive.

Ketan was taken on as a independent Non-Exexcutive Director for Immupharma because it's the London Stock Market requirement under the Corporate Governance Code. Immupharma now have at least two independent Non-Exexcutive Directors which is the minimum requirement.

The same deramping idiot been telling us the sole reason he was hired was to fund raise. If there was going to be a fund raise then so be it, and not because we needed him for it.

Everytime Immupharma need a fund raise, they go and hire a independent Non-Exexcutive Director! Well, really? I never knew that. If that was the case, Immupharma would have by now probably 10 independent Non-Exexcutive Directors on board the number of fund raised they had done.

Span,

What the heck are you moaning on about? Talk some sense man. Have you been sniffing up onetwatmany a..

There's nothing wrong with trading shares. This is capitalism after all.

But there are people who post unfounded rubbish and deramping through and through to scare off others from buying or to scare them off to selling, so they could hopefully depressed the share price for their own deceiving gain. This is equivalent to a boiler room scam. To get people to depart their money. The difference is this social media is free speech and legal.

It's deceiving because onetwatmany damn well know what potential in IMM's share price could happen in the future, despite all his posturing . Believe me, he loves this share. That's why he's fully loaded up. If he really don't believe in IMM, why don't he put his money where his mouth is and get the f... out.

Roger65,

Your deramping supervisor onetwatmany, to join you back in your deramping boiler room scam.

I can read onetwatmany like a book.

He would go quiet when the share price spike up. This is when he would short/top slice out, before the next cycle of share price dip. He would now go on a deramping rage until he get his buy back in price. This is how he accumulates his shares from day one.

The never ending cycle of deramp, buy back in, short/top slice out, deramp, buy back in, short/top slice out, deramp, ...........and so on.

There's no point paying for L2 if you don't trade regularly.